Jun 02, 2012 - NEW YORK, June 2, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced completion of enrollment of the PICASSO 3 trial, an international, randomized, double-blind, placebo-controlled Phase 3 clinical study of palifosfamide in combination with doxorubicin, versus doxorubicin alone, for the treatment of metastatic soft tissue sarcoma (STS) in the front-line setting. Doxorubicin is the current standard of care for the treatment of STS in the front-line setting. (Source: Medical News (via PRIMEZONE))

Jun 02, 2012 - (Source: Molecular Diagnosis)

Jun 02, 2012 - (Source: Molecular Diagnosis)

Jun 02, 2012 - A new study shows that Johnson & Johnson's prostate cancer pill Zytiga dramatically slows the progression of the disease in men who are not yet sick enough to start chemotherapy. Zytiga is already approved for use in patients after chemotherapy including the drug Taxotere has been given. (Source: Forbes.com Healthcare News)

Jun 02, 2012 - CHICAGO (MedPage Today) -- Attacks on a key pathway, used by tumors such as non-small cell lung cancer to shield themselves from the immune system, appear to be yielding positive clinical results, researchers reported. (Source: MedPage Today Meeting Coverage)

Jun 02, 2012 - Working night shifts more than twice a week is linked to increased risk of breast cancer, a Danish study has found. (Source: Nursing Times Breaking News)

Jun 02, 2012 - In this study, we performed genome?wide serum miRNA analysis by the Solexa sequencing followed by validation conducted in the training and verification sets with a stem?loop quantitative reverse?transcription PCR (RT?qPCR) assay from serum samples of 122 untreated astrocytomas patients (WHO grade III ?IV) and 123 normal controls. Identified miRNAs were subsequently examined in 55 grade II, 15 grade I astrocytomas, 11 astrogliosis, 42 other primary brain tumors, and 8 tumor tissues from grade II?IV astrocytomas. In addition, paired serum samples before and after operation were collected from 14 malignant astrocytomas to determine the effect of surgery on the miRNAs' levels. A marked difference in serum miRNA profile was observed between high?grade astrocytomas and normal contr...

Jun 01, 2012 - An experimental drug shows promise in harnessing the immune system to fight cancer, but it is not clear whether the drug will actually help people live longer. (Source: NYT Health)

Jun 01, 2012 - Source: American Cancer Society Related MedlinePlus Page: Health Problems in Pregnancy (Source: MedlinePlus Health News)

Jun 01, 2012 - Two clinical trials show promise for drugs that block cancer's ability to hide (Source: ScienceNOW)